Immunophenotype characterization of rat mesenchymal stromal cells

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Immunology

Background:

• Mesenchymal stromal cells (MSC) exhibit broad therapeutic potential.
• Human and mouse MSC characterization is advanced, but rat BM-MSC remain under-characterized.
• This study focuses on the detailed immunocharacterization of rat bone marrow-derived MSC (rBM-MSC).

Purpose of the Study:

• To detail the isolation, expansion, differentiation, and immunocharacterization of rBM-MSC.
• To establish a standardized method for identifying and characterizing rBM-MSC.
• To facilitate reproducible cell therapy investigations using rBM-MSC.

Main Methods:

• Rat MSC were isolated and expanded using multipotent adult progenitor cell (MAPC) media.
• Cell-surface marker expression was analyzed through 10 passages.
• Multipotency was confirmed via differentiation assays.

Main Results:

• By passage 3, rBM-MSC were identified as CD11b-, CD45-, CD29+, CD49e+, CD73+, CD90+, CD105+, and Stro-1+ without cell sorting.
• Media selection yielded a nearly homogeneous rBM-MSC population.
• The rBM-MSC immunophenotype shifted by passage 10, with decreased CD73, CD105, and Stro-1 expression.

Conclusions:

• Detailed characterization of cell populations is essential for accurate cell therapy research.
• These findings enhance the ability to compare different rBM-MSC populations.
• The study provides a foundation for future rBM-MSC investigations in cell therapy.